Search

Malcolm Cribbs

Examiner (ID: 10271, Phone: (571)270-1566 , Office: P/2497 )

Most Active Art Unit
2497
Art Unit(s)
2432, 2497, 2115
Total Applications
956
Issued Applications
839
Pending Applications
36
Abandoned Applications
93

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18842590 [patent_doc_number] => 20230404994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => MARKERS OF TISSUE AGING AND USES THEREFOR [patent_app_type] => utility [patent_app_number] => 17/860246 [patent_app_country] => US [patent_app_date] => 2022-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/860246
MARKERS OF TISSUE AGING AND USES THEREFOR Jul 7, 2022 Abandoned
Array ( [id] => 19380859 [patent_doc_number] => 20240270729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => (THI)OXAZOLINE PESTICIDES [patent_app_type] => utility [patent_app_number] => 18/569370 [patent_app_country] => US [patent_app_date] => 2022-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569370 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569370
(THI)OXAZOLINE PESTICIDES Jun 14, 2022 Pending
Array ( [id] => 19903045 [patent_doc_number] => 12280029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators [patent_app_type] => utility [patent_app_number] => 17/833315 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 2135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833315 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/833315
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators Jun 5, 2022 Issued
Array ( [id] => 19792153 [patent_doc_number] => 12233076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Stable liquid formulations of cyclophosphamide and processes to prepare the same [patent_app_type] => utility [patent_app_number] => 17/831926 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11909 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831926 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/831926
Stable liquid formulations of cyclophosphamide and processes to prepare the same Jun 2, 2022 Issued
Array ( [id] => 19403510 [patent_doc_number] => 20240287021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => QUATERNARY AMMONIUM SALT COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/563807 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17726 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563807 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563807
QUATERNARY AMMONIUM SALT COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF May 25, 2022 Pending
Array ( [id] => 18604896 [patent_doc_number] => 11746350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => SiRNA, medical compositions, and methods for treating type ii diabetes using the same [patent_app_type] => utility [patent_app_number] => 17/663826 [patent_app_country] => US [patent_app_date] => 2022-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13220 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663826 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/663826
SiRNA, medical compositions, and methods for treating type ii diabetes using the same May 16, 2022 Issued
Array ( [id] => 19379254 [patent_doc_number] => 20240269124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/561247 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29435 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -168 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561247 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/561247
METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS May 15, 2022 Pending
Array ( [id] => 19730104 [patent_doc_number] => 12208090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-28 [patent_title] => Compounds for use in treating depression and migraine [patent_app_type] => utility [patent_app_number] => 17/742417 [patent_app_country] => US [patent_app_date] => 2022-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18661 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742417 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/742417
Compounds for use in treating depression and migraine May 11, 2022 Issued
Array ( [id] => 19331206 [patent_doc_number] => 20240245636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => COMPOSITION FOR INCREASING MUSCLE MASS [patent_app_type] => utility [patent_app_number] => 18/289935 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289935 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/289935
COMPOSITION FOR INCREASING MUSCLE MASS May 9, 2022 Pending
Array ( [id] => 17790309 [patent_doc_number] => 20220249400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL [patent_app_type] => utility [patent_app_number] => 17/730356 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730356 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730356
SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL Apr 26, 2022 Abandoned
Array ( [id] => 18064395 [patent_doc_number] => 20220395482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD [patent_app_type] => utility [patent_app_number] => 17/726934 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726934 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/726934
GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD Apr 21, 2022 Abandoned
Array ( [id] => 17774885 [patent_doc_number] => 20220241234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => METHODS OF TREATING MIXED DYSLIPIDEMIA [patent_app_type] => utility [patent_app_number] => 17/725357 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23811 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725357 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/725357
METHODS OF TREATING MIXED DYSLIPIDEMIA Apr 19, 2022 Abandoned
Array ( [id] => 17774943 [patent_doc_number] => 20220241292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM [patent_app_type] => utility [patent_app_number] => 17/723771 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723771 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/723771
Pharmaceutical compositions comprising meloxicam Apr 18, 2022 Issued
Array ( [id] => 19318259 [patent_doc_number] => 20240239801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/287524 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287524 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287524
PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Apr 18, 2022 Pending
Array ( [id] => 17759885 [patent_doc_number] => 20220233497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => CANNABINOID DERIVATIVES AND METHODS FOR THEIR PREPARATION [patent_app_type] => utility [patent_app_number] => 17/723935 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 692 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/723935
Cannabinoid derivatives and methods for their preparation Apr 18, 2022 Issued
Array ( [id] => 19263568 [patent_doc_number] => 20240207265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => TREATMENT OF CNS DISEASES WITH sGC STIMULATORS [patent_app_type] => utility [patent_app_number] => 18/287616 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287616 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287616
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS Apr 18, 2022 Pending
Array ( [id] => 19279858 [patent_doc_number] => 20240216330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS [patent_app_type] => utility [patent_app_number] => 18/285123 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285123 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/285123
COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS Mar 31, 2022 Pending
Array ( [id] => 18978786 [patent_doc_number] => 11903940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Methods of treating disease with levoketoconazole [patent_app_type] => utility [patent_app_number] => 17/655632 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10540 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655632 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/655632
Methods of treating disease with levoketoconazole Mar 20, 2022 Issued
Array ( [id] => 17702802 [patent_doc_number] => 20220202808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => Compositions For Affecting Weight Loss [patent_app_type] => utility [patent_app_number] => 17/699600 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699600 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699600
Compositions For Affecting Weight Loss Mar 20, 2022 Abandoned
Array ( [id] => 19650007 [patent_doc_number] => 12171767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Uses of DPP IV inhibitors [patent_app_type] => utility [patent_app_number] => 17/681997 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8944 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681997
Uses of DPP IV inhibitors Feb 27, 2022 Issued
Menu